Adcock loses AIDS business to Aspen; Meda snaps up GSK consumer products;

@FiercePharma: Merck KGaA taps new pharma chief for its pharma ops Article | Follow @FiercePharma

> Adcock Ingram, Africa's largest over-the-counter drug company, shares fell after rival Aspen Pharmacare got a bigger portion of a 4.16 billion-rand ($610 million) contract to supply AIDS treatments. News

> Arthritis patients taking opioid pain drugs had a higher risk of bone fractures and death compared with people taking other painkillers, according to a study that looked at Medicare claims records. Item

> Japan's Otsuka Holdings (4578.T) could rise about 5 percent on its market debut Wednesday after pricing its $2.4 billion IPO conservatively to reflect investor worries about its heavy reliance on profits from one drug. Report

> Ahmedabad, India-based Lincoln Pharmaceuticals (LPL), has tied up with U.S.-based Human Biosciences (HBI) for exclusive marketing and distribution of two of HBI's wound care management products in India. Item

> Meda bought three over-the-counter drug products from GlaxoSmithKline for about $34 million. Story

> Momenta Pharmaceuticals said it has completed its underwritten public offering of 4 million shares of its common stock, offered at a price of $14.35 per share. Story

> Hungarian drugmaker Richter has signed a long-term biosimilars license and collaboration agreement with Japanese group Mochida Pharmaceutical. Report

> Certain women who take estrogen alone, without progestin, to treat menopause symptoms may actually be protected from breast cancer. Article 

Biotech News

 @FierceBiotech: Lab tech firm rounds up $17M in Series B cash. News | Follow @FierceBiotech

 @JohnCFierce: Lilly suspended late-stage tasisulam trial after recording a dozen patient deaths. 3 setbacks in 3 months. Report  | Follow @JohnCFierce

> Lilly dealt another blow as investigators suspend Ph3 melanoma trial. Article

> Zerhouni replaces Cluzel as Sanofi R&D czar. News

Biotech Research News

> New stem cell strategy cures diabetes in mice. Story

> DoD awards $1.3M grant to develop artificial blood. Item

> Cell transplant gets paralyzed monkey back on his feet. Story

> NASA stokes fiery debate over bacterium study. Article

> Investigators use microthread to stitch cells into place. Report

Manufacturing News

> J&J/McNeil plays contractor card in Rolaids recall. Report

> Freezing DTap vax has unintended effect. News

> In turnabout, India to send inspectors overseas. Article

> Shortages highlight supply chain communications problem. Item

And finally ... In addition to being good for the heart, high levels of so-called "good" cholesterol may protect against Alzheimer's disease, U.S. researchers said. Report

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.